AMANDA CHARPENTIER: Open Payments
NPI 1700458015 · GRAY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 106 payments from 21 companies in 2025. Trend: 2023 $15 · 2024 $174 · 2025 $2,148
Food & beverage: $2,148
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 11 | $309 |
| UCB, Inc. | 11 | $262 |
| ABBVIE INC. | 16 | $233 |
| PFIZER INC. | 13 | $226 |
| Lundbeck LLC | 9 | $208 |
| Lilly USA, LLC | 10 | $192 |
| Biogen, Inc. | 6 | $128 |
| Eisai Inc. | 6 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| CSL Behring | 4 | $77 |
Products named: NUPLAZID, VYEPTI, NURTEC ODT, LEQEMBI, Briviact, AMYVID, UBRELVY, QULIPTA.
Industry payments across LA — which companies pay providers there.
